Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/8/2025

Antibiotic Management for Postoperative Total Knee Incision with Erythema

Assessment and Treatment

  • The Infectious Diseases Society of America recommends initiating systemic antibiotics with a first-generation cephalosporin, such as cefazolin, or an antistaphylococcal penicillin, such as nafcillin, for methicillin-susceptible Staphylococcus aureus (MSSA), or vancomycin if risk factors for MRSA are present, in patients with postoperative total knee arthroplasty incision showing increased redness 1, 2
  • Antibiotics are indicated if the patient has systemic signs of infection, including erythema and induration extending >5 cm from the wound edge, temperature >38.5°C, heart rate >110 beats/minute, or white blood cell count >12,000/µL 1, 2

Primary Antibiotic Selection

  • The American College of Surgeons recommends cefazolin 1-2g IV every 8 hours or nafcillin 1.5-2g IV every 4-6 hours as first-line options for MSSA or unknown susceptibility, providing optimal coverage for S. aureus and streptococci 1, 5
  • Vancomycin 15 mg/kg IV every 12 hours is recommended for patients with MRSA risk factors, such as nasal MRSA colonization, prior MRSA infection, recent hospitalization, or recent antibiotic use 1, 2

Surgical Management and Duration of Therapy

  • The Infectious Diseases Society of America recommends suture removal plus incision and drainage for confirmed surgical site infections, with antibiotics serving as adjunctive therapy 1, 2
  • The duration of antibiotic therapy depends on the extent of infection and surgical intervention, ranging from 5-7 days for superficial SSI with systemic signs to 4-6 weeks of IV antibiotics for deep infection with hardware retention 1, 2, 3

Special Considerations

  • For patients with documented beta-lactam allergy, vancomycin 15 mg/kg IV every 12 hours or clindamycin 600-900 mg IV every 8 hours (if susceptibility confirmed) may be used 1, 4
  • Recent evidence suggests cefazolin can be safely used in many patients labeled as penicillin-allergic, with lower SSI rates compared to clindamycin/vancomycin without increased hypersensitivity reactions 1